Xenetic Biosciences, Inc.
XBIO
$2.82
$0.02991.07%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 589.90K | 593.30K | 648.80K | 614.20K | 726.40K |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 589.90K | 593.30K | 648.80K | 614.20K | 726.40K |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | 589.90K | 593.30K | 648.80K | 614.20K | 726.40K |
SG&A Expenses | 657.80K | 656.60K | 705.70K | 745.70K | 1.13M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 1.31M | 1.54M | 1.75M | 1.11M | 2.06M |
Operating Income | -724.40K | -942.40K | -1.10M | -499.50K | -1.34M |
Income Before Tax | -688.70K | -903.10K | -1.05M | -436.70K | -1.27M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -688.70K | -903.10K | -1.05M | -436.70K | -1.27M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -688.70K | -903.10K | -1.05M | -436.70K | -1.27M |
EBIT | -724.40K | -942.40K | -1.10M | -499.50K | -1.34M |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | -0.45 | -0.59 | -0.68 | -0.28 | -0.83 |
Normalized Basic EPS | -0.28 | -0.37 | -0.43 | -0.18 | -0.52 |
EPS Diluted | -0.45 | -0.59 | -0.68 | -0.28 | -0.83 |
Normalized Diluted EPS | -0.28 | -0.37 | -0.43 | -0.18 | -0.52 |
Average Basic Shares Outstanding | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M |
Average Diluted Shares Outstanding | 1.54M | 1.54M | 1.54M | 1.54M | 1.54M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |